CONMED Corporation
CNMD
$34.51
-$0.26-0.75%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.05% | 10.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.05% | 10.44% | |||
| Cost of Revenue | -31.15% | 32.62% | |||
| Gross Profit | 2.93% | -6.93% | |||
| SG&A Expenses | 10.46% | -3.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.24% | 14.88% | |||
| Operating Income | -38.17% | -26.08% | |||
| Income Before Tax | -37.25% | 584.60% | |||
| Income Tax Expenses | -63.82% | 785.01% | |||
| Earnings from Continuing Operations | -17.39% | 485.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.39% | 485.48% | |||
| EBIT | -38.17% | -26.08% | |||
| EBITDA | -20.45% | -19.02% | |||
| EPS Basic | -16.36% | 484.96% | |||
| Normalized Basic EPS | -49.35% | -33.37% | |||
| EPS Diluted | -16.74% | 500.56% | |||
| Normalized Diluted EPS | -49.29% | -33.30% | |||
| Average Basic Shares Outstanding | -1.23% | 0.04% | |||
| Average Diluted Shares Outstanding | -1.32% | -0.06% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -- | -0.83% | |||